{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:46:51Z","timestamp":1792025211267,"version":"4.4.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Heart transplantation is the definitive treatment for end-stage heart failure. While the number of heart transplant performed yearly in the United States has nearly doubled in the last decade, median survival has stagnated, largely due to the complications posed by lifelong immunosuppression. A shift towards precision medicine is needed to achieve the optimal balance between risk of allograft rejection and drug-related toxicities to improve post-transplant outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Novel molecular based diagnostic tools and biomarkers are being investigated, and hold promise in evaluating graft health and assessing immune state.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The use of circulating biomarkers and molecular diagnostics such as human and viral cell-free DNA, tissue-based gene expression profiling, and circulating microRNAs, will allow for more comprehensive assessment of post-transplant immune activity and rejection risk to personalize patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11897-026-00784-7","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:04:09Z","timestamp":1791975849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision Immunosuppression in Heart Transplantation: Biomarker-Guided Therapy Comes of Age"],"prefix":"10.1007","volume":"23","author":[{"given":"Karthik","family":"Sreedhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"issue":"8\u20139","key":"784_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.acvd.2019.05.004","volume":"112","author":"T Petroni","year":"2019","unstructured":"Petroni T, D\u2019Alessandro C, Combes A, Golmard JL, Brechot N, Barreda E, et al. Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation. Arch Cardiovasc Dis. 2019;112(8\u20139):485\u201393.","journal-title":"Arch Cardiovasc Dis"},{"issue":"10","key":"784_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","volume":"34","author":"LH Lund","year":"2015","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report\u20132015; Focus Theme: Early Graft Failure. J Heart Lung Transpl. 2015;34(10):1244\u201354.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"784_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1056\/NEJMoa2500456","volume":"393","author":"AM Williams","year":"2025","unstructured":"Williams AM, Trahanas JM, Bommareddi S, Lima B, DeVries SA, Lowman J, et al. Rapid Recovery of Donor Hearts for Transplantation after Circulatory Death. N Engl J Med. 2025;393(3):267\u201374.","journal-title":"N Engl J Med"},{"issue":"10","key":"784_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","volume":"38","author":"KK Khush","year":"2019","unstructured":"Khush KK, Cherikh WS, Chambers DC, Harhay MO, Hayes D Jr., Hsich E, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report\u2009\u2013\u20092019; focus theme: Donor and recipient size match. J Heart Lung Transpl. 2019;38(10):1056\u201366.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"784_CR5","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.healun.2025.02.188","volume":"44","author":"P Shah","year":"2025","unstructured":"Shah P, Kim PJ, Schlendorf KH, Colvin MM, DeVore AD, Eisen HJ, et al. Primary Results of the Development of Non-Invasive Cell-Free DNA to Supplant INvasivE Biopsy in Heart Transplantation (DEFINE-HT) Study. J Heart Lung Transplantation. 2025;44(4):S90.","journal-title":"J Heart Lung Transplantation"},{"issue":"10","key":"784_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.healun.2022.07.018","volume":"41","author":"E Hsich","year":"2022","unstructured":"Hsich E, Singh TP, Cherikh WS, Harhay MO, Hayes D Jr., Perch M, et al. The International thoracic organ transplant registry of the international society for heart and lung transplantation: Thirty-ninth adult heart transplantation report-2022; focus on transplant for restrictive heart disease. J Heart Lung Transpl. 2022;41(10):1366\u201375.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"784_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","volume":"137","author":"J Stehlik","year":"2018","unstructured":"Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 Years of Clinical Heart Transplantation in Circulation: In-Depth State-of-the-Art Review. Circulation. 2018;137(1):71\u201387.","journal-title":"Circulation"},{"issue":"10","key":"784_CR8","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1097\/TP.0000000000003307","volume":"104","author":"A Multani","year":"2020","unstructured":"Multani A, Moayedi Y, Puing A, Henricksen E, Garvert DW, Gomez CA, et al. Recent Trends of Infectious Complications Following Heart Transplantation. Transplantation. 2020;104(10):e284\u201394.","journal-title":"Transplantation"},{"issue":"10","key":"784_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","volume":"36","author":"LH Lund","year":"2017","unstructured":"Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. J Heart Lung Transpl. 2017;36(10):1037\u201346.","journal-title":"J Heart Lung Transpl"},{"issue":"2","key":"784_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/ehf2.12585","volume":"7","author":"S Roest","year":"2020","unstructured":"Roest S, Hesselink DA, Klimczak-Tomaniak D, Kardys I, Caliskan K, Brugts JJ, et al. Incidence of end-stage renal disease after heart transplantation and effect of its treatment on survival. ESC Heart Fail. 2020;7(2):533\u201341.","journal-title":"ESC Heart Fail"},{"issue":"3","key":"784_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.healun.2011.08.012","volume":"31","author":"SP Pinney","year":"2012","unstructured":"Pinney SP, Balakrishnan R, Dikman S, Nair A, Hammond K, Domanski M, et al. Histopathology of renal failure after heart transplantation: a diverse spectrum. J Heart Lung Transpl. 2012;31(3):233\u20137.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"784_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jacc.2017.10.077","volume":"71","author":"JC Youn","year":"2018","unstructured":"Youn JC, Stehlik J, Wilk AR, Cherikh W, Kim IC, Park GH, et al. Temporal Trends of De Novo Malignancy Development After Heart Transplantation. J Am Coll Cardiol. 2018;71(1):40\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"784_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","volume":"25","author":"E Ingulli","year":"2010","unstructured":"Ingulli E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol. 2010;25(1):61\u201374.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"784_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","volume":"6","author":"MC Deng","year":"2006","unstructured":"Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transpl. 2006;6(1):150\u201360.","journal-title":"Am J Transpl"},{"issue":"15","key":"784_CR15","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1073\/pnas.1013924108","volume":"108","author":"TM Snyder","year":"2011","unstructured":"Snyder TM, Khush KK, Valantine HA, Quake SR. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci U S A. 2011;108(15):6229\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"784_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","volume":"18","author":"M Grskovic","year":"2016","unstructured":"Grskovic M, Hiller DJ, Eubank LA, Sninsky JJ, Christopherson C, Collins JP, et al. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients. J Mol Diagn. 2016;18(6):890\u2013902.","journal-title":"J Mol Diagn"},{"issue":"10","key":"784_CR17","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1111\/ajt.15339","volume":"19","author":"KK Khush","year":"2019","unstructured":"Khush KK, Patel J, Pinney S, Kao A, Alharethi R, DePasquale E, et al. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Am J Transpl. 2019;19(10):2889\u201399.","journal-title":"Am J Transpl"},{"issue":"7","key":"784_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.healun.2022.04.002","volume":"41","author":"PJ Kim","year":"2022","unstructured":"Kim PJ, Olymbios M, Siu A, Wever Pinzon O, Adler E, Liang N, et al. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation. J Heart Lung Transpl. 2022;41(7):919\u201327.","journal-title":"J Heart Lung Transpl"},{"issue":"12","key":"784_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1161\/CIRCULATIONAHA.120.049098","volume":"143","author":"S Agbor-Enoh","year":"2021","unstructured":"Agbor-Enoh S, Shah P, Tunc I, Hsu S, Russell S, Feller E, et al. Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation. 2021;143(12):1184\u201397.","journal-title":"Circulation"},{"issue":"11","key":"784_CR20","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/TP.0000000000003240","volume":"104","author":"S Dholakia","year":"2020","unstructured":"Dholakia S, De Vlaminck I, Khush KK. Adding Insult on Injury: Immunogenic Role for Donor-derived Cell-free DNA? Transplantation. 2020;104(11):2266\u201371.","journal-title":"Transplantation"},{"issue":"40","key":"784_CR21","doi-asserted-by":"publisher","first-page":"E5503","DOI":"10.1073\/pnas.1508736112","volume":"112","author":"K Sun","year":"2015","unstructured":"Sun K, Jiang P, Chan KC, Wong J, Cheng YK, Liang RH, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci U S A. 2015;112(40):E5503\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"784_CR22","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/cc4894","volume":"10","author":"A Rhodes","year":"2006","unstructured":"Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10(2):R60.","journal-title":"Crit Care"},{"issue":"12","key":"784_CR23","first-page":"2395","volume":"62","author":"AI Ahmed","year":"2016","unstructured":"Ahmed AI, Soliman RA, Samir S. Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery. Clin Lab. 2016;62(12):2395\u2013404.","journal-title":"Clin Lab"},{"issue":"4","key":"784_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.krcp.2015.09.002","volume":"34","author":"DW Jeong","year":"2015","unstructured":"Jeong DW, Moon JY, Choi YW, Moon H, Kim K, Lee YH, et al. Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients. Kidney Res Clin Pract. 2015;34(4):201\u20136.","journal-title":"Kidney Res Clin Pract"},{"key":"784_CR25","doi-asserted-by":"publisher","first-page":"11260","DOI":"10.3389\/ti.2023.11260","volume":"36","author":"J Bohmer","year":"2023","unstructured":"Bohmer J, Wasslavik C, Andersson D, Stahlberg A, Jonsson M, Wahlander H, et al. Absolute Quantification of Donor-Derived Cell-Free DNA in Pediatric and Adult Patients After Heart Transplantation: A Prospective Study. Transpl Int. 2023;36:11260.","journal-title":"Transpl Int"},{"issue":"9","key":"784_CR26","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.ajt.2025.04.021","volume":"25","author":"PJ Kim","year":"2025","unstructured":"Kim PJ, Olympios M, Sideris K, Tseliou E, Tran TY, Carter S, et al. A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation. Am J Transpl. 2025;25(9):1895\u2013905.","journal-title":"Am J Transpl"},{"issue":"12","key":"784_CR27","doi-asserted-by":"publisher","first-page":"e011592","DOI":"10.1161\/CIRCHEARTFAILURE.124.011592","volume":"17","author":"JF Goldberg","year":"2024","unstructured":"Goldberg JF, Tian X, Bon A, Xu Y, Gerhard E, Brower R, et al. Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft Dysfunction. Circ Heart Fail. 2024;17(12):e011592.","journal-title":"Circ Heart Fail"},{"issue":"241","key":"784_CR28","doi-asserted-by":"publisher","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","volume":"6","author":"I De Vlaminck","year":"2014","unstructured":"De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6(241):241ra77.","journal-title":"Sci Transl Med"},{"issue":"10","key":"784_CR29","doi-asserted-by":"publisher","first-page":"102614","DOI":"10.1016\/j.jchf.2025.102614","volume":"13","author":"A Mehta","year":"2025","unstructured":"Mehta A, DeFilippis EM, Stehlik J, Jackson AM, Kobashigawa JA, Shah P. Contemporary Antibody-Mediated Rejection in Heart Transplantation: JACC: Heart Failure Position Statement. JACC Heart Fail. 2025;13(10):102614.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"784_CR30","doi-asserted-by":"publisher","first-page":"102716","DOI":"10.1016\/j.jchf.2025.102716","volume":"14","author":"PJ Kim","year":"2026","unstructured":"Kim PJ, Alam AH, Teuteberg JJ, Khush KK, Pinney SP, Cheng RK, et al. Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection: An Analysis of the Surveillance HeartCare Outcomes Registry. JACC Heart Fail. 2026;14(1):102716.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"784_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.healun.2024.10.006","volume":"44","author":"A Mehta","year":"2025","unstructured":"Mehta A, Goldberg J, Bagchi P, Marboe C, Shah KB, Najjar SS, et al. Pathologist interrater reliability and clinical implications of elevated donor-derived cell-free DNA beyond heart transplant rejection, on behalf of the GRAfT investigators. J Heart Lung Transplantation. 2025;44(5):803\u201312.","journal-title":"J Heart Lung Transplantation"},{"issue":"11","key":"784_CR32","doi-asserted-by":"publisher","first-page":"e012787","DOI":"10.1161\/CIRCHEARTFAILURE.125.012787","volume":"18","author":"CM Moeller","year":"2025","unstructured":"Moeller CM, Fernandez Valledor A, Oren D, Rahman S, Baranowska J, Hertz A, et al. Significance of Elevated Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Negative Endomyocardial Biopsies: A Dawn of a New Era. Circ Heart Fail. 2025;18(11):e012787.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"784_CR33","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/TP.0b013e31826e19e2","volume":"94","author":"MG Crespo-Leiro","year":"2012","unstructured":"Crespo-Leiro MG, Zuckermann A, Bara C, Mohacsi P, Schulz U, Boyle A, et al. Concordance among pathologists in the second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II). Transplantation. 2012;94(11):1172\u20137.","journal-title":"Transplantation"},{"issue":"11","key":"784_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","volume":"36","author":"PF Halloran","year":"2017","unstructured":"Halloran PF, Potena L, Van Huyen JD, Bruneval P, Leone O, Kim DH, et al. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System. J Heart Lung Transpl. 2017;36(11):1192\u2013200.","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"784_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1161\/CIRCULATIONAHA.116.022907","volume":"135","author":"A Loupy","year":"2017","unstructured":"Loupy A, Van Duong JP, Hidalgo L, Reeve J, Racape M, Aubert O, et al. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection. Circulation. 2017;135(10):917\u201335.","journal-title":"Circulation"},{"issue":"3","key":"784_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.healun.2021.08.004","volume":"41","author":"PF Halloran","year":"2022","unstructured":"Halloran PF, Madill-Thomsen K, Aliabadi-Zuckermann AZ, Cadeiras M, Crespo-Leiro MG, Depasquale EC, et al. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes. J Heart Lung Transpl. 2022;41(3):334\u201344.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"784_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.healun.2009.12.015","volume":"29","author":"JA Kobashigawa","year":"2010","unstructured":"Kobashigawa JA, Kiyosaki KK, Patel JK, Kittleson MM, Kubak BM, Davis SN, et al. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. J Heart Lung Transpl. 2010;29(5):504\u20138.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"784_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.healun.2008.10.001","volume":"28","author":"JW Rossano","year":"2009","unstructured":"Rossano JW, Denfield SW, Kim JJ, Price JF, Jefferies JL, Decker JA, et al. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transpl. 2009;28(1):26\u201331.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"784_CR39","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","volume":"42","author":"A Velleca","year":"2023","unstructured":"Velleca A, Shullo MA, Dhital K, Azeka E, Colvin M, DePasquale E, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transpl. 2023;42(5):e1\u2013141.","journal-title":"J Heart Lung Transpl"},{"issue":"6","key":"784_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s11897-017-0362-8","volume":"14","author":"P Shah","year":"2017","unstructured":"Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep. 2017;14(6):454\u201364.","journal-title":"Curr Heart Fail Rep"},{"issue":"45","key":"784_CR41","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","volume":"35","author":"JP Van Duong","year":"2014","unstructured":"Van Duong JP, Tible M, Gay A, Guillemain R, Aubert O, Varnous S, et al. MicroRNAs as non-invasive biomarkers of heart transplant rejection. Eur Heart J. 2014;35(45):3194\u2013202.","journal-title":"Eur Heart J"},{"issue":"11","key":"784_CR42","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.healun.2018.06.010","volume":"37","author":"A Di Francesco","year":"2018","unstructured":"Di Francesco A, Fedrigo M, Santovito D, Natarelli L, Castellani C, De Pascale F, et al. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transpl. 2018;37(11):1329\u201340.","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"784_CR43","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.healun.2020.05.018","volume":"39","author":"I Constanso-Conde","year":"2020","unstructured":"Constanso-Conde I, Hermida-Prieto M, Barge-Caballero E, Nunez L, Pombo-Otero J, Suarez-Fuentetaja N, et al. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation. J Heart Lung Transpl. 2020;39(10):1100\u20138.","journal-title":"J Heart Lung Transpl"},{"issue":"10","key":"784_CR44","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.healun.2022.06.019","volume":"41","author":"P Shah","year":"2022","unstructured":"Shah P, Agbor-Enoh S, Bagchi P, deFilippi CR, Mercado A, Diao G, et al. Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. J Heart Lung Transpl. 2022;41(10):1401\u201313.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"784_CR45","first-page":"440","volume":"113","author":"I Sukma Dewi","year":"2017","unstructured":"Sukma Dewi I, Celik S, Karlsson A, Hollander Z, Lam K, McManus JW, et al. Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression. Cardiovasc Res. 2017;113(5):440\u201352.","journal-title":"Cardiovasc Res"},{"key":"784_CR46","doi-asserted-by":"crossref","unstructured":"Goldberg JF, Bagchi P, Mercado A, Shah KB, Najjar SS, Tchoukina I et al. Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs. Circ Heart Fail. 2026:e013141.","DOI":"10.1161\/CIRCHEARTFAILURE.124.013141"},{"issue":"5","key":"784_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nri.2016.40","volume":"16","author":"A Mehta","year":"2016","unstructured":"Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"33","key":"784_CR48","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 2006;103(33):12481\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"784_CR49","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O\u2019Connell","year":"2007","unstructured":"O\u2019Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA. 2007;104(5):1604\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"784_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.12045","volume":"253","author":"AM Beaulieu","year":"2013","unstructured":"Beaulieu AM, Bezman NA, Lee JE, Matloubian M, Sun JC, Lanier LL. MicroRNA function in NK-cell biology. Immunol Rev. 2013;253(1):40\u201352.","journal-title":"Immunol Rev"},{"issue":"5654","key":"784_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303(5654):83\u20136.","journal-title":"Science"},{"issue":"1","key":"784_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3128","volume":"12","author":"M McHeyzer-Williams","year":"2011","unstructured":"McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol. 2011;12(1):24\u201334.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"784_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4049\/jimmunol.1101563","volume":"189","author":"NA Barnes","year":"2012","unstructured":"Barnes NA, Stephenson S, Cocco M, Tooze RM, Doody GM. BLIMP-1 and STAT3 counterregulate microRNA-21 during plasma cell differentiation. J Immunol. 2012;189(1):253\u201360.","journal-title":"J Immunol"},{"issue":"11","key":"784_CR54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1084\/jem.20140338","volume":"211","author":"D Lu","year":"2014","unstructured":"Lu D, Nakagawa R, Lazzaro S, Staudacher P, Abreu-Goodger C, Henley T, et al. The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. J Exp Med. 2014;211(11):2183\u201398.","journal-title":"J Exp Med"},{"issue":"4","key":"784_CR55","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/eji.201444637","volume":"45","author":"M Porstner","year":"2015","unstructured":"Porstner M, Winkelmann R, Daum P, Schmid J, Pracht K, Corte-Real J, et al. miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2. Eur J Immunol. 2015;45(4):1206\u201315.","journal-title":"Eur J Immunol"},{"issue":"3","key":"784_CR56","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI74347","volume":"125","author":"G Murugaiyan","year":"2015","unstructured":"Murugaiyan G, da Cunha AP, Ajay AK, Joller N, Garo LP, Kumaradevan S, et al. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Investig. 2015;125(3):1069\u201380.","journal-title":"J Clin Investig"},{"issue":"10","key":"784_CR57","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1371\/journal.pone.0001020","volume":"2","author":"H Wu","year":"2007","unstructured":"Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE. 2007;2(10):e1020.","journal-title":"PLoS ONE"},{"issue":"10","key":"784_CR58","doi-asserted-by":"publisher","first-page":"e46082","DOI":"10.1371\/journal.pone.0046082","volume":"7","author":"R Yao","year":"2012","unstructured":"Yao R, Ma YL, Liang W, Li HH, Ma ZJ, Yu X, et al. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS ONE. 2012;7(10):e46082.","journal-title":"PLoS ONE"},{"issue":"7","key":"784_CR59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.healun.2003.08.005","volume":"23","author":"MA Arnau-Vives","year":"2004","unstructured":"Arnau-Vives MA, Almenar L, Hervas I, Osa A, Martinez-Dolz L, Rueda J, et al. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. J Heart Lung Transpl. 2004;23(7):850\u20136.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"784_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/TP.0000000000000378","volume":"99","author":"LC Battes","year":"2015","unstructured":"Battes LC, Caliskan K, Rizopoulos D, Constantinescu AA, Robertus JL, Akkerhuis M, et al. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients. Transplantation. 2015;99(3):580\u20135.","journal-title":"Transplantation"},{"issue":"9","key":"784_CR61","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.healun.2004.08.018","volume":"24","author":"A Hammerer-Lercher","year":"2005","unstructured":"Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poelzl G, Laufer G, et al. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation. J Heart Lung Transpl. 2005;24(9):1444.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"784_CR62","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.healun.2017.11.003","volume":"37","author":"RT Cole","year":"2018","unstructured":"Cole RT, Gandhi J, Bray RA, Gebel HM, Yin M, Shekiladze N, et al. Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation. J Heart Lung Transpl. 2018;37(4):503\u201312.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"784_CR63","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/TP.0000000000003876","volume":"106","author":"SJ Fitzsimons","year":"2022","unstructured":"Fitzsimons SJ, Evans JDW, Rassl DM, Lee KK, Strachan FE, Parameshwar J, et al. High-sensitivity Cardiac Troponin Is Not Associated With Acute Cellular Rejection After Heart Transplantation. Transplantation. 2022;106(5):1024\u201330.","journal-title":"Transplantation"},{"issue":"17","key":"784_CR64","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1161\/01.CIR.102.17.2100","volume":"102","author":"MS Eisenberg","year":"2000","unstructured":"Eisenberg MS, Chen HJ, Warshofsky MK, Sciacca RR, Wasserman HS, Schwartz A, et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation. 2000;102(17):2100\u20134.","journal-title":"Circulation"},{"issue":"7","key":"784_CR65","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/TP.0000000000005258","volume":"109","author":"JF Goldberg","year":"2025","unstructured":"Goldberg JF, deFilippi CR, Lockhart C, McNair ER, Sinha SS, Kong H, et al. Proteomics in Acute Heart Transplant Rejection, on Behalf of the GRAfT Investigators. Transplantation. 2025;109(7):1230\u201340.","journal-title":"Transplantation"},{"key":"784_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2022.06.020","volume":"364","author":"I de Lange","year":"2022","unstructured":"de Lange I, Petersen TB, de Bakker M, Akkerhuis KM, Brugts JJ, Caliskan K, et al. Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study). Int J Cardiol. 2022;364:77\u201384.","journal-title":"Int J Cardiol"},{"issue":"3","key":"784_CR67","doi-asserted-by":"publisher","first-page":"e2300047","DOI":"10.1002\/prca.202300047","volume":"18","author":"C Wang","year":"2024","unstructured":"Wang C, Feng G, Zhao J, Xu Y, Li Y, Wang L, et al. Screening of novel biomarkers for acute kidney transplant rejection using DIA-MS based proteomics. Proteom Clin Appl. 2024;18(3):e2300047.","journal-title":"Proteom Clin Appl"},{"key":"784_CR68","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.jhlto.2024.100110","volume":"5","author":"RG Dalsgaard","year":"2024","unstructured":"Dalsgaard RG, Clemmensen TS, Eiskjaer H, Poulsen SH, Bjerre KP. Proteomics early after heart transplantation and relation to coronary intimal changes and prognosis. JHLT Open. 2024;5:100110.","journal-title":"JHLT Open"},{"issue":"1","key":"784_CR69","doi-asserted-by":"publisher","first-page":"e13765","DOI":"10.1111\/ctr.13765","volume":"34","author":"A Almufleh","year":"2020","unstructured":"Almufleh A, Zhang L, Mielniczuk LM, Stadnick E, Davies RA, Du Q, et al. Biomarker discovery in cardiac allograft vasculopathy using targeted aptamer proteomics. Clin Transpl. 2020;34(1):e13765.","journal-title":"Clin Transpl"},{"issue":"12","key":"784_CR70","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.healun.2021.07.024","volume":"40","author":"LK Truby","year":"2021","unstructured":"Truby LK, Kwee LC, Agarwal R, Grass E, DeVore AD, Patel CB, et al. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation. J Heart Lung Transpl. 2021;40(12):1589\u201398.","journal-title":"J Heart Lung Transpl"},{"issue":"3","key":"784_CR71","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.healun.2017.07.012","volume":"37","author":"PJ Kennel","year":"2018","unstructured":"Kennel PJ, Saha A, Maldonado DA, Givens R, Brunjes DL, Castillero E, et al. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. J Heart Lung Transpl. 2018;37(3):409\u201317.","journal-title":"J Heart Lung Transpl"},{"issue":"1","key":"784_CR72","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s43856-025-00999-0","volume":"5","author":"J Burrello","year":"2025","unstructured":"Burrello J, Panella S, Barison I, Castellani C, Burrello A, Airale L, et al. Machine learning-assisted assessment of extracellular vesicles can monitor cellular rejection after heart transplant. Commun Med (Lond). 2025;5(1):288.","journal-title":"Commun Med (Lond)"},{"issue":"5","key":"784_CR73","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.cell.2013.10.034","volume":"155","author":"I De Vlaminck","year":"2013","unstructured":"De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell. 2013;155(5):1178\u201387.","journal-title":"Cell"},{"issue":"Pt 1","key":"784_CR74","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1099\/vir.0.070094-0","volume":"96","author":"D Focosi","year":"2015","unstructured":"Focosi D, Macera L, Boggi U, Nelli LC, Maggi F. Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells. J Gen Virol. 2015;96(Pt 1):115\u20137.","journal-title":"J Gen Virol"},{"issue":"3","key":"784_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.6002\/ect.2017.0105","volume":"19","author":"M Ramzi","year":"2021","unstructured":"Ramzi M, Iravani Saadi M, Zarei T, Yaghobi R, Arandi N. Association Between Cytotoxic T-Lymphocyte Antigen 4 Gene Polymorphisms and Torque Teno Virus Infection After Hematopoietic Stem Cell Transplantation. Exp Clin Transpl. 2021;19(3):259\u201363.","journal-title":"Exp Clin Transpl"},{"issue":"12","key":"784_CR76","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/TP.0b013e31817615e6","volume":"85","author":"F Maggi","year":"2008","unstructured":"Maggi F, Ricci V, Bendinelli M, Nelli LC, Focosi D, Papineschi F, et al. Changes In CD8\u2009+\u200957+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia. Transplantation. 2008;85(12):1867\u20138.","journal-title":"Transplantation"},{"issue":"8","key":"784_CR77","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1111\/ajt.15810","volume":"20","author":"K Doberer","year":"2020","unstructured":"Doberer K, Schiemann M, Strassl R, Haupenthal F, Dermuth F, Gorzer I, et al. Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial. Am J Transpl. 2020;20(8):2081\u201390.","journal-title":"Am J Transpl"},{"issue":"4","key":"784_CR78","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ajt.15145","volume":"19","author":"M Fernandez-Ruiz","year":"2019","unstructured":"Fernandez-Ruiz M, Albert E, Gimenez E, Ruiz-Merlo T, Parra P, Lopez-Medrano F, et al. Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation. Am J Transpl. 2019;19(4):1139\u201349.","journal-title":"Am J Transpl"},{"key":"784_CR79","doi-asserted-by":"publisher","first-page":"15074","DOI":"10.3389\/ti.2025.15074","volume":"38","author":"K Doberer","year":"2025","unstructured":"Doberer K, Kapps S, Haupenthal F, Bond G. Immune Monitoring Goes Viral - Torque Teno Virus for Immunologic Risk Stratification After Kidney Transplantation. Transpl Int. 2025;38:15074.","journal-title":"Transpl Int"},{"issue":"4","key":"784_CR80","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1016\/j.healun.2020.01.1023","volume":"39","author":"K Uyanik-Uenal","year":"2020","unstructured":"Uyanik-Uenal K, Perkmann-Nagele N, Wittmann F, Ceran E, Aliabadi-Zuckermann A, Laufer G, et al. Torque Teno Virus DNA Load after Heart Transplantation and Its Association with the Strength of Immunosuppression: Preliminary Data of a Prospective Single Center Study. J Heart Lung Transplantation. 2020;39(4):S128.","journal-title":"J Heart Lung Transplantation"},{"issue":"12","key":"784_CR81","doi-asserted-by":"publisher","first-page":"110720","DOI":"10.1016\/j.humimm.2023.110720","volume":"84","author":"R Berg","year":"2023","unstructured":"Berg R, Clemmensen TS, Petersen MS, Mogensen LJH, Christiansen M, Rolid K, et al. Kinetics of Torque Teno virus in heart transplant patients. Hum Immunol. 2023;84(12):110720.","journal-title":"Hum Immunol"},{"issue":"2","key":"784_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/FTD.0b013e31816babef","volume":"30","author":"E Thervet","year":"2008","unstructured":"Thervet E, Anglicheau D, Legendre C, Beaune P. Role of pharmacogenetics of immunosuppressive drugs in organ transplantation. Ther Drug Monit. 2008;30(2):143\u201350.","journal-title":"Ther Drug Monit"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-026-00784-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-026-00784-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-026-00784-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:07:16Z","timestamp":1792022836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11897-026-00784-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s11897-026-00784-7","relation":{},"ISSN":["1546-9549"],"issn-type":[{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PS reports consulting for Natera and has stock incentives in Procyrion.","order":2,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Palak Shah receives consulting income from Natera Inc.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"48"}}